First-in-Human Total-Body PET/CT Imaging Using<sup>89</sup>Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First-in-Human Total-Body PET/CT Imaging Using⁸⁹Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma

Published:2024-09-05 Issue: Volume: Page:jnumed.124.268074
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kulkarni Harshad R.,Maupin Kevin A.,Brennan Tina,Forsberg Jens,Rogers Dan,Olson Mark,Mancini Brandon R.,Chang Anthony,Chandana Sreenivasa R.,Kobayashi Ryohei

Publisher

Society of Nuclear Medicine

Reference4 articles.

1. Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis;Jinfeng;Int J Gastrointest Cancer.,2003

2. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas

3. MUC5AC expression in various tumor types and non-neoplastic tissue: a tissue microarray study on 10 399 tissue samples;Rico;Technol Cancer Res Treat.,2021

4. Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody;Nakata;Nucl Med Biol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP